Document is current

Article History

Received: 7 October 2025

Accepted: 17 March 2026

First Online: 24 March 2026

Declarations

:

: This retrospective analysis was reviewed by the Ethics Committee of Shanxi Cancer Hospital in April 2025 and approved for the study, with reference number KY2025037. During the study, the Ethics Committee continued to review all materials and acknowledged that they met ethical requirements. The ethical review criteria for this study are based on the Helsinki Declaration.This study is a retrospective analysis, and a waiver of informed consent application explanation has been submitted during ethical review. The patients who have undergone treatment in this study were treated according to relevant diagnosis and treatment guidelines, without any new drugs or treatment methods, and no personal information of the patients was displayed in the data in the paper. There was no violation of the patient's privacy rights, and it has been reviewed and approved by our hospital's ethics committee.In response to this issue, the hospital ethics committee has provided a dedicated document for us to upload in the system.The name of the ethics review committee is: Ethics Committee of Shanxi Cancer Hospital, Chinese Academy of Medical Sciences.The exemption agreement is based on the following laws and regulations: "Measures for Ethical Review of Life Science and Medical Research Involving Human Subjects"

: Not applicable.

: The authors declare no competing interests.